ALYVIAH DURHAM: Open Payments
NPI 1275289746 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 84 payments from 14 companies in 2025. Trend: 2023 $737 · 2024 $2,090 · 2025 $2,299
Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $641 |
| Regeneron Healthcare Solutions, Inc. | 8 | $297 |
| ABBVIE INC. | 16 | $293 |
| UCB, Inc. | 8 | $191 |
| Incyte Corporation | 8 | $173 |
| LEO Pharma Inc. | 8 | $172 |
| Botanix SB Inc | 3 | $143 |
| Organon LLC | 2 | $143 |
| PFIZER INC. | 5 | $91 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $62 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, OPZELURA, SOFDRA, VTAMA, ADBRY, CIBINQO.
Industry payments across CA — which companies pay providers there.
